Argan (AGX) is rated as a 'Strong Buy' due to significant macro trends in AI and data center demand, which have driven its backlog to $2.9 billion, more than double the previous year. Although revenue growth slowed to 12.7% year-over-year in Q4 2026, the large backlog is expected to convert into strong revenue growth over the next three years. Despite a high price-to-earnings ratio of 69, projected revenue growth of 32% and margin expansion above 20% justify a potential market cap increase of 34–88% from current levels. Key risks include macroeconomic changes affecting AI spending and possible delays in backlog conversion, but management's strong track record supports confidence in the outlook.
STMicroelectronics announced a $1.5 billion issuance of new convertible senior bonds in two tranches, with maturities of 5 and 7 years, alongside the early repayment of $750 million of zero-coupon convertible bonds due in 2027. The new bonds offer fi...
Regentis Biomaterials shares surged over 500% intraday before falling 9.15% in after-hours trading following the company's announcement that it withdrew its Registration Statement for a public offering. The regenerative medicine firm decided not to p...
Elon Musk's SpaceX recently went public, raising questions about a potential IPO for its Starlink subsidiary. Data from prediction market Kalshi shows only a 7-10% chance of a Starlink IPO announcement before mid-2027. Meanwhile, Musk predicts SpaceX...
Goodfirms has published its 2026 rankings of top technology service providers across six categories: mobile app, software, web development, digital marketing, SEO, and AI development. These rankings are based on over 1.2 million verified client revie...
Alvotech announced a $152 million public offering and concurrent private placement of ordinary shares priced at $3.75 each. The public offering includes 22.7 million shares, with an option for underwriters to buy an additional 3.4 million shares. The...
